$NXGL

NEXGEL Reports Second Quarter 2026 Financial Results

NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEXGEL Reports Second Quarter 2026 Financial Results LANGHORNE, Pa. – August 17, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content

Original reporting
Published Aug 17, 2026, 12:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 12:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NXGL
Neutral
low confidence
Mentioned
$NXGL
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NXGLNeutralLow
01

Why it matters

The filing itself is a procedural disclosure that becomes tradable once Exhibit 99.1 financials and any updates are reviewed; the excerpt does not provide those figures.

02

Market read

This is a quarterly results disclosure event for NXGL, but the excerpt contains no financial data to quantify upside or downside.

03

What to watch

Traders should focus on Exhibit 99.1 details (revenue, gross margin, cash burn, liquidity, and any forward guidance) since those are not present in the scraped body.

Relevance 7/10Novelty 2/10Timing: filed Aug 17, 2026 premarket/early session with results press release attached

Background

The company submitted SEC Form 8-K under Item 2.02, stating it issued a press release with results for the quarter ended June 30, 2026 and other corporate updates.

Company-level read

Ticker impact

$NXGLNeutralLow confidence
Context

NexGel filed an 8-K furnishing its quarter ended June 30, 2026 results via Exhibit 99.1, making NXGL the filing’s subject.

Expected impact

Near-term price reaction is possible once traders read Exhibit 99.1, but this text alone provides no numbers to forecast direction.

Evidence & confidence

The filing states a press release was issued and attached, yet the provided content omits the quarter’s reported metrics, so the incremental trading information cannot be assessed from the excerpt.

Market effects

No sector read-through is provided in the excerpt beyond routine quarterly reporting.

None indicated.

None indicated.

Counterpoint

Because the excerpt lacks the actual results, the market may already be positioned for the release, making any reaction more about the specific numbers and outlook than the existence of the filing.

Key entities

  • NexGel, Inc.

    Subject of the 8-K filing, reporting quarter ended June 30, 2026 results via attached Exhibit 99.1.

  • Ian Blackman

    CFO signing the 8-K.

Related articles

$JPMHighAI 9/10

JPMorgan Chase Reports Strong Q3 2026 Earnings with Focus on Div

JPMorgan Chase reported Q3 2026 earnings with net income of $15.3B, revenue up 8% YoY to $50.9B, and EPS of $5.57. The company offers a 1.88% dividend yield with a 26% payout ratio and 13.2% 3-year growth rate. Its GF Score is 84/100, indicating strong financial health, though financial strength is rated poorly. Insiders sold $125.1M in shares, while 32 gurus hold positions, with mixed activity.

$JPMMedAI 8/10

Big banks show clean credit, but investors fear what comes next

JPMorgan (JPM), Citigroup (C), Goldman Sachs (GS), and Wells Fargo (WFC) reported Q3 earnings. JPMorgan's equities revenue beat estimates, while fixed income missed. Goldman Sachs saw investment banking revenue rise 21%. Wells Fargo's net interest margin held steady. Citigroup topped net interest income estimates and raised its dividend. Analysts noted mixed results and future credit risk concerns due to a flattening yield curve.

$JPMMed

JPMorgan Sees Deal Delays, Not Cancellations, During Market Uncertainty - JPMorgan Chase (NYSE:JPM)

JPMorgan Chase (NYSE:JPM) reported adjusted earnings of $5.75 per share, missing estimates. The company provided a 2027 net interest income outlook of $107 billion, with 25% growth from the yield curve. CFO Jeremy Barnum noted strong consumer spending and a healthy investment banking pipeline, though deals may be delayed. Management warned of AI risks and tightening credit standards. Shares were up 0.39% at $335.60 during the earnings call.

$CMedAI 8/10

Citigroup's Q3 Earnings Show Strong Revenue Growth Despite Mixed

Citigroup reported Q3 EPS of $2.85, beating estimates, with revenue up 8% YoY to $23.85B. Growth in Services and Wealth offset mixed capital markets performance. Net interest income rose 14% YoY, while operating expenses fell 2% YoY. Management remains optimistic about its turnaround strategy, with RoTCE improving to 11.5%.